Michael Zdanowski
Corporate Officer/Principal chez Medeor Therapeutics, Inc.
Fortune : 3 366 $ au 31/03/2024
Profil
Michael Zdanowski is currently the Vice President-GMP Operations at New York Stem Cell Foundation, Inc. and the Senior VP-Biopharmaceutical Operations at Medeor Therapeutics, Inc. He was previously the Chief Technology Officer at Talaris Therapeutics, Inc. from 2020 to 2023.
He received an undergraduate degree from the University of Pennsylvania and an MBA from Columbia University School of the Arts.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
0,00% | 17/04/2023 | 147 ( 0,00% ) | 3 366 $ | 31/03/2024 |
Postes actifs de Michael Zdanowski
Sociétés | Poste | Début |
---|---|---|
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
New York Stem Cell Foundation, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de Michael Zdanowski
Sociétés | Poste | Fin |
---|---|---|
TOURMALINE BIO, INC. | Chief Tech/Sci/R&D Officer | 28/04/2023 |
Formation de Michael Zdanowski
University of Pennsylvania | Undergraduate Degree |
Columbia University School of the Arts | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
New York Stem Cell Foundation, Inc. | Miscellaneous |
Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |